1. “Understanding the pathophysiology of stress echocardiography as a diagnostic tool for
the evaluation of valve disease”. 40th Panhellenic Congress of Cardiology, Ioannina, October
2019
2. «Light-intensity exercise and its role on cardiovascular prevention. Is less better than
none?”. Panhellenic Seminars of Hellenic Society of Cardiology Working Groups 2021,
Thessaloniki, May 2021

3. “The most Impactful Antithrombotic Trials in 2020-2021. Highlights from ACC 21. RIVER-
ATLANTIS trials”. Advanced Learning on Platelets & Thrombosis International Course (ALPIC),

Kalavrita, May 2021
4. “Selecting adult patients with venous thromboembolism for indefinite anticoagulation”.
Panhellenic Seminars of Hellenic Society of Cardiology Working Groups 2022, Ioannina, April
2022
5. “Forum of Trainees & Young Cardiologists- Clinical Trial Highlights- Prevention”.
International Congress of Cardiology, Athens, October 2022
6. “Antithrombotic therapy of patients undergoing noncardiac operations according to 2022
ESC guidelines”. Advanced Learning on Platelets & Thrombosis International Course (ALPIC),
Kalavrita, November 2022
7. “Primary Healthcare Setting Scenarios- Diagnostic approach of palpitations”. Diagnostic
Algorithms and Therapeutic Approaches in Internal Medicine, Ioannina, September 2024
8. “A 21-year-old professional basketball player is successfully resuscitated via CPR after a
cardiac arrest during warm-up. Post-arrest ECG shows negative T waves in the inferior and
lateral leads. Can he safely continue his professional career?” 5th Panhellenic Congress
“Sports Cardiology”, Delfoi, September 2024
9. “A 34-year-old male with a seven-year history of hypertension—expect the unexpected.”
Cardio Dialogues, Athens, November 2024

1. “Understanding the pathophysiology of stress echocardiography as a diagnostic tool for
the evaluation of valve disease”. 40th Panhellenic Congress of Cardiology, Ioannina, October
2019
2. «Light-intensity exercise and its role on cardiovascular prevention. Is less better than
none?”. Panhellenic Seminars of Hellenic Society of Cardiology Working Groups 2021,
Thessaloniki, May 2021

3. “The most Impactful Antithrombotic Trials in 2020-2021. Highlights from ACC 21. RIVER-
ATLANTIS trials”. Advanced Learning on Platelets & Thrombosis International Course (ALPIC),

Kalavrita, May 2021
4. “Selecting adult patients with venous thromboembolism for indefinite anticoagulation”.
Panhellenic Seminars of Hellenic Society of Cardiology Working Groups 2022, Ioannina, April
2022
5. “Forum of Trainees & Young Cardiologists- Clinical Trial Highlights- Prevention”.
International Congress of Cardiology, Athens, October 2022
6. “Antithrombotic therapy of patients undergoing noncardiac operations according to 2022
ESC guidelines”. Advanced Learning on Platelets & Thrombosis International Course (ALPIC),
Kalavrita, November 2022
7. “Primary Healthcare Setting Scenarios- Diagnostic approach of palpitations”. Diagnostic
Algorithms and Therapeutic Approaches in Internal Medicine, Ioannina, September 2024
8. “A 21-year-old professional basketball player is successfully resuscitated via CPR after a
cardiac arrest during warm-up. Post-arrest ECG shows negative T waves in the inferior and
lateral leads. Can he safely continue his professional career?” 5th Panhellenic Congress
“Sports Cardiology”, Delfoi, September 2024
9. “A 34-year-old male with a seven-year history of hypertension—expect the unexpected.”
Cardio Dialogues, Athens, November 2024

1. A.S. Papazoglou, A. Kartas, A. Samaras, I. Vouloagkas, E. Vrana, D.V. Moysidis, E. Akrivos,
G. Kotzampasis, A. Baroutidou, A. Papanastasiou, E. Liampas, M. Botis, E. Karagiannidis, N.

Stalikas, H. Karvounis, A. Tzikas, G. Giannakoulas. “Prognostic significance of diabetes
mellitus in patients with atrial fibrillation”. Cardiovascular Diabetology. Feb 2021;20:40
2. A. Kartas , A. Samaras, E. Akrivos, E. Vrana , A.S. Papazoglou , D.V. Moysidis , A.
Papanastasiou, A. Baroutidou, M. Botis, E. Liampas, I. Vouloagkas, E. Karagiannidis, H.
Karvounis, J. Parissis, A. Tzikas, G. Giannakoulas. “Τhe association of heart failure across left
ventricular ejection fraction with mortality in atrial fibrillation”. ESC Heart Fail. Aug
2021;8(4):3189-3197.
3. V. Patsiou, D.V. Moysidis, A. Kartas, A. Samaras, AS Papazoglou, A. Bekiaridou, C.
Tsagkaris, I. Vouloagkas, A. Loudovikou , A. Papanastasiou, E. Vrana, A. Baroutidou, M. Botis,
E. Liampas , H. Karvounis, A. Tzikas, G. Giannakoulas. “Education level predicts mortality and

morbidity in hospitalised patients with atrial fibrillation”. Hellenic J Cardiol. 2022 May-
Jun;65:19-24.

4. A. Baroutidou, A. Kartas, A. Samaras, A. S. Papazoglou, E. Vrana, D.V. Moysidis, E. Akrivos,
A. Papanastasiou, I. Vouloagkas, M. Botis, E. Liampas, A.G. Karagiannidis , E. Karagiannidis,
G. Efthimiadis, H. Karvounis, A. Tzikas, G. Giannakoulas. “Associations of Atrial Fibrillation
Patterns with Mortality and Cardiovascular Events: Implications of the MISOAC-AF Trial”. J
Cardiovasc Pharmacol Ther. Jan-Dec 2022;27:10742484211069422.
5. D. Moysidis, A. Kartas , A. Samaras, A.S. Papazoglou, E. Akrivos, I. Vouloagkas, A.
Papanastasiou, E. Vrana, A. Baroutidou , M. Botis , E. Liampas, C. Tsagkaris, E. Karagiannidis,
H. Karvounis, A. Tzikas , G. Giannakoulas. “Rhythm control versus rate control in patients
with atrial fibrillation and heart failure across the left ventricular ejection fraction
spectrum”. Hellenic J Cardiol. Mar 2022;S1109-9666(22)00028-8.
6. A. Papanastasiou, A. Kartas, A. Samaras, E. Vrana, A.S. Papazoglou, D.V. Moysidis, A.
Baroutidou, M. Botis, E. Liampas, I. Vouloagkas, E. Mareti, E. Karagiannidis, H. Karvounis, A.
Tzikas, G. Giannakoulas. “Oral anticoagulation patterns and prognosis in octogenarian
patients with atrial fibrillation”. Journal of thrombosis and thrombolysis. May
2022;53(4):851-860.
7. E. Liampas, A. Kartas, A. Samaras, A.S. Papazoglou, D.V. Moysidis, E. Vrana, M. Botis, A.
Papanastasiou, A. Baroutidou, I. Vouloagkas, E. Karagiannidis, E. Akrivos, D. Tsalikakis, V.
Fyntanidou, H. Karvounis, A. Tzikas, G. Giannakoulas. “Renal function and mortality in
patients with atrial fibrillation”. Journal of Cardiovascular Medicine: July 2022;23(7):430-438
8. M. Botis, A. Kartas, A. Samaras, E. Akrivos, E. Vrana, E. Liampas, A. Papazoglou, D.
Moysidis, A. Papanastasiou, A. Baroutidou, H. Karvounis, A. Tzikas, J. Parissis, S. Drakos, G.
Giannakoulas. Clinical Outcomes in Patients with Atrial Fibrillation treated with Digoxin,
according to the presence of Heart Failure: Insights from the MISOAC- AF trial. Hellenic
Journal of Cardiology, https://doi.org/10.1016/j.hjc.2022.08.001
9. Chiotis S, Doundoulakis I, Pagkalidou E, Piperis C, Zafeiropoulos S, Botis M, Haidich AB,
Economou F, Chierchia GB, de Asmundis C, Tsiachris D, Vassilikos VP, Giannopoulos G. Total
Atrial Conduction Time as a Predictor of Atrial Fibrillation Recurrence: A Systematic Review
and Meta-Analysis. Cardiol Rev. 2023 Jul 18. Epub ahead of print. PMID: 37462720.

10. Tsiachris D, Botis M, Doundoulakis I, Bartsioka LI, Tsioufis P, Kordalis A, Antoniou CK,
Tsioufis K, Gatzoulis KA. Electrocardiographic Characteristics, Identification, and
Management of Frequent Premature Ventricular Contractions. Diagnostics (Basel). 2023 Sep
29;13(19):3094. doi: 10.3390/diagnostics13193094. PMID: 37835837; PMCID:
PMC10572222.
11. Tsiachris D, Papakonstantinou PE, Doundoulakis I, Tsioufis P, Botis M, Dimitriadis K,
Leontsinis I, Kordalis A, Antoniou CK, Mantzouranis E, Iliakis P, Vlachakis PK, Gatzoulis KA,
Tsioufis K. Anticoagulation Status and Left Atrial Appendage Occlusion Indications in
Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity
Snapshot (HECMOS) Sub-Study. Medicina (Kaunas). 2023 Oct 23;59(10):1881. doi:
10.3390/medicina59101881. PMID: 37893599; PMCID: PMC10608124.
12. Vlachakis PK, Tsiachris D, Doundoulakis I, Tsioufis P, Kordalis A, Botis M, Leontsinis I,
Antoniou CK, Papachrysostomou C, Dimitroula V, Maneta E, Chalkitis V, Kotsakis T,
Skantzikas P, Kafkas N, Sidiropoulos G, Roussos D, Trikas A, Koudounis G, Kolettis TM,
Smyrnioudis N, Christakos D, Chasikidis C, Gatzoulis KA, Tsioufis K. Therapeutic inertia in
rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic
Cardiorenal Morbidity Snapshot (HECMOS) study. J Cardiol. 2023 Nov 17:S0914-
5087(23)00275-7. doi: 10.1016/j.jjcc.2023.11.004. Epub ahead of print. PMID: 37979719.
13. Doundoulakis I, Nedios S, Zafeiropoulos S, Vitolo M, Della Rocca DG, Kordalis A, Shamloo
AS, Koliastasis L, Marcon L, Chiotis S, Sorgente A, Soulaidopoulos S, Imberti JF, Botis M,
Pannone L, Gatzoulis KA, Sarkozy A, Stavrakis S, Boriani G, Boveda S, Tsiachris D, Chierchia
GB, de Asmundis C. Atrial fibrillation burden: Stepping beyond the categorical
characterization. Heart Rhythm. 2024 Aug 27:S1547-5271(24)03269-7.

1. Role of echocardiography in managing acute pulmonary embolism, hcs.gr, January 2020,
https://www.hcs.gr/wp-content/uploads/2021/11/yperixokardiografia.pdf
2. Acute mitral regurgitation, cardiologynews.gr, April 2020,

https://cardiologynews.gr/2020/04/04/oxia-aneparkia-mitroidous-valvidas-mia-epigousa-
katastasi-stin-kardiologia/

3. Compass Trial and subgroup analysis, cardiologynews.gr, October 2021,
https://cardiologynews.gr/2021/10/04/meleti-compass-kai-analysi-ypo-omadon-tis
subgroup-analysis/
4. ACC/AHA/SCAI 2021 Guidelines for Coronary Revascularization, cardiologynews.gr,

February 2022, https://cardiologynews.gr/2022/02/06/katefthyntiries-odigies-tou-2021-ton-
acc-aha-scai-schetika-me-tin-stefaniaia-epanangeiosi/

5. Recurrent Pericarditis: What’s new in Imaging modalities and therapeutic approach,

cardiologynews.gr, October 2022, https://cardiologynews.gr/2022/10/12/ypotropiazousa-
perikarditidayp-exelixeis-stis-apeikonistikes-technikes-kai-tin-therapeftiki-prosengisi/

1. M. Botis, G. Pattakos, N. Kouvelas, I. Goudevenos . “Mitral valve regurgitation: From the
diagnostic challenge to the difficult therapeutic choice.” Ελληνική Καρδιολογική
Επιθεώρηση. 2019; 60: 134-144
2. G. Pattakos, M. Botis, I. Goudevenos. «Antithrombotic therapy for prosthetic heart
valves”. Καρδιά και Αγγεία. 2020;XXV/2:102-106
3. M. Botis, G. Pattakos, D. Nikas, A. Patrianakos, I. Goudevenos. “Defining the optimal
intervention strategy in severe aortic stenosis”. Ελληνική Καρδιολογική Επιθεώρηση.
2020;61(4):224-231
4. M. Botis, G. Pattakos, T. Babali, I. Goudevenos. “Secondary Prevention After Coronary
Artery Bypass Graft Surgery”. Ελληνική Καρδιολογική Επιθεώρηση. 2021; 62: 267-273
5. M. Botis, G. Pattakos, D. Nikas, I. Goudevenos. “ACC/AHA/SCAI 2021 Guidelines for
Coronary Revascularization”. Ελληνική Καρδιολογική Επιθεώρηση. 2022; 63: 86-91

ORAL ABSTRACT PRESENTATIONS
1. N. Sakellaris, M. Botis, E. Oflidis, A. Daiou, M. Spandonidou. “Comparative study of risk
factors for acute myocardial infarction on Greek armed forces and the general population”.
22ND Balkan Military Medical Committee, Belgrade, September 2017
2. M. Botis, A. Tsokanis, K. Kasmas, V. Pylarinou, N. Kouvelas. “Exercise ECG testing as
screening tool in Hellenic Air Force flying personnel: A retrospective observational study”.
29th Polythematic Medical Symposium of Hellenic Armed Forces, Athens, February 2020
3. M. Botis, A. Kartas, A. Samaras, E. Akrivos, E. Vrana, E. Liampas, A. Papazoglou, D.
Moysidis, A. Papanastasiou, A. Baroutidou, H. Karvounis, A. Tzikas, G. Giannakoulas. “Digoxin
and association with mortality in patients discharged from hospital with atrial fibrillation,
with or without heart failure”. European Heart Rhythm Association (EHRA) Online Congress,
April 2021
4. P.K.Vlachakis, D. Tsiachris, I. Doundoulakis, P. Tsioufis, A. Kordalis, M. Botis, I. Leontsinis,
C. K. Antoniou, C. Papachrysostomou, V. Dimitroula, E. Maneta, V. Chalkitis, T. Kotsakis, P.
Skantzikas, N. Kafkas, G. Sidiropoulos, D. Roussos, G. Koudounis, K. A Gatzoulis, K. Tsioufis.
“Therapeutic inertia in rhythm control strategies in hospitalized patients with atrial
fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study”. 44th
Panhellenic Congress of Cardiology, Thessaloniki, October 2023
5. M. Botis, D. Tsiachris, P. Papakonstantinou, I. Leontsinis, I. Doundoulakis, P. Tsioufis, P.
Iliakis, G. Oikonomou, C. K. Antoniou, T. Kolettis, N. Smyrnioudis, D. Christakos, C. Chasikidis,
K. Tsioufis. “Anticoagulation status and left atrial appendage occlusion indications in
hospitalized cardiology patients with atrial fibrillation: A Hellenic Cardiorenal Morbidity
Snapshot (HECMOS) sub-study”. 44th Panhellenic Congress of Cardiology, Thessaloniki,
October 2023

1. G. Fotos, A. Arvanitaki, A. Samaras, G. Dividis, D. Vasdeki, E. Kotsi, P. Tsoukra, E.
Forozidou, T. Panagiotis, E. Thomaidou, E. Paschou, M. Botis, A. Tzikas, Ch. Karvounis, G.
Giannakoulas. “Antithrombotic treatment of hospitalized patients with non valvural atrial
fibrillation based on renal function.” Hellenic Journal of Cardiology. 2017; 58(A): 25
2. A. Samaras, E. Michou, G. Fotos, G. Dividis, D. Vasdeki, E. Kotsi, P. Tsoukra, E. Forozidou, T.
Panagiotis, A. Kartas, E. Paschou, M. Botis, Ch. Karvounis, G. Giannakoulas. A. Tzikas.
“Antithrombotic treatment of hospitalized patients with atrial fibrillation and heart failure”.
Hellenic Journal of Cardiology. 2017; 58(A): 90
3. E. Thomaidou, A. Samaras, G. Fotos, G. Dividis, D. Vasdeki, E. Kotsi, P. Tsoukra, E.
Forozidou, T. Panagiotidis, E. Paschou, M. Botis, Ch. Karvounis, G. Giannakoulas, A. Tzikas.
“The effect of diabetes mellitus on the epidiomiological profile of patients with atrial
fibrillation”. Hellenic Journal of Cardiology. 2017; 58(A): 92

4. D. Vlachopoulou, C. Balomenakis, A. Kartas, A. Samaras, A. Papazoglou, D. Moysidis, E.
Vrana, A. Papanastasiou, A. Baroutidou, M. Botis, E. Liampas, I. Vouloagkas, E. Karagiannidis,

H. Karvounis, A. Tzikas, G. Giannakoulas. “Cardioselective versus non- cardioselective beta-
blockers and outcomes in patients with Atrial Fibrillation and Chronic Obstructive Pulmonary

Disease” 42nd Panhellenic Congress of Cardiology, Athens, October 2021
5. D.V. Moysidis, A. Kartas, A. Samaras, AS. Papazoglou, A. Bekiaridou, V. Patsiou, I.
Vouloagkas, A. Papanastasiou, E. Vrana, A. Baroutidou, M. Botis, C. Tsagkaris, E.
Karagiannidis, A. Tzikas, G. Giannakoulas. “Prescription rates of guideline-directed medical
treatment across the eGFR continuum in patients with heart failure: Insights from the
MISOAC-AF trial”. European Heart Failure Association Congress, Madrid, May 2022
6. P. Vlachakis, I. Kachrimanidis, S. Drogkaris, M. Pliatsika, D. Richter, G. Giannopoulos, V.
Karampetsos, A. Martinos, A. Kordalis, A. Makris, M. Botis, A. Boulbou, A. Ntamelou, F.P.
Tatakis, G.G. Fotis, C. Komporozos, P. Roditis, C. Chrysocchoou, G. Filippatos, K. Tsioufis.
“HEllenic Cardiorenal MOrbidity Snapshot (HECMOS). Anticoagulant Atrial Fibrillation
Therapy in concomitant renal dusfunction”. International Congress of Cardiology, Athens,
October 2022
7. M. Botis, I. Doundoulakis, CK. Antoniou, A. Kordalis, G. Deligiannis, P. Tsioufis, KA.
Gatzoulis, K. Tsioufis, D. Tsiachris. “Association of superior vena cava isolation with improved
outcomes in atrial fibrillation ablation”. European Heart Rhythm Association (EHRA)
Congress, April 2024

1. “Registry study: Snapshot of hospitalized cardiologic patients”, organized by the Hellenic
Cardiovascular Research Society. Participation on behalf of the 251 Hellenic Air Force
General Hospital, November 2018
2. «Registry of Hypertensive or/and Diabetic Patients, hospitalized in Greek Cardiology
Departments”, organized by the Hellenic Cardiovascular Research Society. Participation on
behalf of the 251 Hellenic Air Force General Hospital, November 2019
3. «Registry of Hypertensive or/and Diabetic Patients, hospitalized in Greek Cardiology
Departments”, organized by the Hellenic Cardiovascular Research Society. Participation on
behalf of the 251 Hellenic Air Force General Hospital, April 2021
4. “Cardiomyopathies and comorbidities. Registry of the main comorbidities of the patients
hospitalized in the Cardiology Departments of the country”, organized by the Hellenic
Cardiovascular Research Society. Participation on behalf of the 251 Hellenic Air Force
General Hospital, May 2022